Davis Aaron I. 4
4 · Tango Therapeutics, Inc. · Filed Jun 8, 2023
Insider Transaction Report
Form 4
Davis Aaron I.
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2023-06-06+5,000→ 5,000 total - Award
Stock Option (Right to Buy)
2023-06-06+30,000→ 30,000 totalExercise: $3.55Exp: 2023-06-06→ Common Stock (30,000 underlying)
Holdings
- 7,123,642(indirect: See footnote)
Common Stock
- 6,988,450(indirect: See footnote)
Common Stock
- 268,524(indirect: See footnote)
Common Stock
Footnotes (5)
- [F1]These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in its entirety on the earlier of: (i) June 6, 2024 and (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
- [F2]These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital (ii) Boxer Asset Management Inc. , (iii) Joseph C. Lewis, (iv) BCTG Holdings, LLC, (v) MVA Investors, LLC ("MVA Investors"), and (vi) Aaron I. Davis (collectively, the "Boxer Group"). The Reporting Person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein.
- [F3]These securities are owned directly by MVA Investors, which may be deemed to be a member of the Boxer Group. The Reporting Person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein.
- [F4]These securities are owned directly by BCTG Holdings, LLC, which may be deemed to be a member of the Boxer Group. The Reporting Person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein.
- [F5]This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year beginning on July 6, 2023, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.